Position in EVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,107
-$15,518 QoQ
Shares Held
10,043
-23.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
201,159 | $108,993,980 | |
| 2 | HLN |
Haleon plc
|
9,264,255 | $86,435,499 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
629,806 | $69,870,677 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,250,639 | $51,313,718 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
659,493 | $42,174,577 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,059,778 | $35,905,278 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
2,235,821 | $11,022,597 | |
| 8 | EOLS |
Evolus, Inc.
|
1,508,518 | $10,469,114 |
All Filings in EVO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,107 | 10,043 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $40,625 | 13,190 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||